Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona - Paul Summers - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-06-05 05:56:31 Ribbon symbolism Benzoates HER2/neu Paclitaxel Biomarker Breast cancer		Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona Add to Reading List Source URL: s3.amazonaws.com Download Document from Source Website File Size: 672,91 KB Share Document on Facebook